Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

Marker Therapeutics-Investor-Presentation 2.19.2019

418 views

Published on

Marker Therapeutics (NASDAQ: MRKR)
Marker Therapeutics, Inc is a clinical-stage immuno-oncology company specializing in the development of next-generation T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications.

Published in: Health & Medicine
  • Be the first to comment

  • Be the first to like this

×